The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic is a
challenge for all participants in the healthcare system. At the beginning of the pandemic …

Objective We systematically reviewed the literature on COVID-19 in patients with multiple
sclerosis (MS). Methods We searched PubMed, Scopus, EMBASE, CINAHL, Web of …

Objective This study was undertaken to assess the impact of immunosuppressive and
immunomodulatory therapies on the severity of coronavirus disease 2019 (COVID‐19) in …

The CoronaVirus Disease 19 (COVID-19) pandemic is a threat of particular concern for
people affected by chronic immune-mediated diseases, such as multiple sclerosis (MS), who …

Background The COVID-19 pandemic challenges neurologists in counselling patients with
multiple sclerosis (pwMS) regarding their risk by SARS-CoV-2 and in guiding disease …

Objective To understand COVID-19 characteristics in people with multiple sclerosis (MS)
and identify high-risk individuals due to their immunocompromised state resulting from the …

Objective To identify risk factors for an increased lethality of COVID-19 in patients with
multiple sclerosis (MS). Methods We searched scientific databases to identify cohort studies …

Abstract Background and Purpose The coronavirus disease 2019 (COVID‐19) pandemic
challenges neurologists in counseling multiple sclerosis (MS) patients with respect to their …

Background and purpose Limited information is available on incidence and outcomes of
COVID‐19 in patients with multiple sclerosis (MS). This study investigated the risks of SARS …

Background and Objectives It is unclear how multiple sclerosis (MS) affects the severity of
COVID-19. The aim of this study is to compare COVID-19–related outcomes collected in an …